← All patents

US20220409663A1

Engineered t cells and tumor-infiltrating lymphocytes to overcome …

University of Texas System

Abstract

Embodiments of the disclosure provide methods and compositions that facilitate cancer treatment including at least because they concern therapies that circumvent the tumor microenvironment. In specific embodiments, compositions are utilized for therapy that utilize tumor-infiltrating lymphocytes …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Samantha Marie FIX
Priority date
November 27, 2019
Filing date
November 25, 2020
Publication date
December 29, 2022
Language
en
Metadata fetched
August 29, 2026 00:29